Paclitaxel as albumin-bound nanoparticles with carboplatin for untreated non-small-cell lung cancer (terminated appraisal)

  • Technology appraisal
  • TA362
  • Published: 

History

Documents created during the development process.

Final scope

Final matrix

Draft scope for consultation (pre-referral) - May 2015

Provisional matrix (pre-referral) - May 2015